RARA and neoplasm: RAR activated by retinoic acid, exerts antiproliferative effects in tumor cells and translocation or fusion involving promyelocytic leukemia with RARα leads to acute promyelocytic leukemia (APL) in hematopoietic myeloid cells [119].